Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; glycerol dibehenate; magnesium stearate; lactose monohydrate; colloidal anhydrous silica; maltodextrin; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: glycerol dibehenate; maltodextrin; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; sodium starch glycollate type a; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: maltodextrin; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; glycerol dibehenate; sodium starch glycollate type a; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: glycerol dibehenate; lactose monohydrate; sodium starch glycollate type a; maltodextrin; magnesium stearate; colloidal anhydrous silica; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

United States - English - NLM (National Library of Medicine)

marina biotech - perindopril arginine (unii: tft5im1kgb) (perindoprilat - unii:2uv6znq92k), amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - perindopril arginine 3.5 mg - prestalia contains perindopril arginine, an angiotensin converting enzyme inhibitor, and amlodipine, a dihydropyridine calcium channel blocker, and is indicated for the treatment of hypertension, to lower blood pressure. prestalia may be used in patients whose blood pressure is not adequately controlled on monotherapy. prestalia may be used as initial therapy in patients likely to need multiple drugs to achieve blood pressure goals. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including amlodipine and the ace inhibitor class to which perindopril principally belongs. there are no controlled trials demonstrating risk reduction with prestalia. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithr

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 5 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; croscarmellose sodium - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 13.87 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose - is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 6.935 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - coveram is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Canada - English - Health Canada

mylan pharmaceuticals ulc - perindopril arginine - tablet - 2.5mg - perindopril arginine 2.5mg - angiotensin-converting enzyme inhibitors